Dr. Dan Barouch, who runs the Center for Virology and Vaccine Research at Beth Israel Deaconess Medical Center, which helped develop a COVID vaccine for Johnson & Johnson, said that […]
“We are not going to be able to completely stop transmission, and we’re not going to be able to get rid of this virus in the human population,” said Dr. […]
It also appears that HV.1 could also be slightly better at escaping prior immunity to COVID-19, but not enough to cause alarm, Dr. Dan Barouch, director of the Center for […]
“Whenever a new variant dominates, then by definition it has an advantage,” said Dr. Dan Barouch, the head of the Center for Virology and Vaccine Research at Beth Israel Deaconess […]
Vaccination rates have bottomed out just as some experts predict a COVID surge over the holidays. The JN.1 variant, which has triggered steep increases in waste water levels across Europe and is […]
Dozens of mucosal COVID-19 vaccines are in development (see ‘High hopes’) and several have been approved in countries including China and India. But according to an 8 December report by […]
At this point, it’s clear from all the infections that the vaccine isn’t living up to early hopes. “The initial impression that these vaccines were 95% effective against symptomatic infection […]
“When we gave the vaccine directly to the lung, we saw a dramatic improvement in … immunity and protection in the lung itself and in the nose, leading to near complete […]
Dan Barouch, MD, PhD, Chief of the Center for Virology and Vaccine Research, has been selected as the recipient of the 2023 Paragon Award for Research Excellence from the Doris […]
HV.1 is descended from EG.5 and is highly similar to it. There isn’t data yet on how well the new vaccines perform against HV.1, but Dr. Dan Barouch, the head […]
